Pediatrix Medical Group, Inc. (MD)
NYSE · Healthcare
Pediatrix Medical Group, Inc. EBITDA 2016–2025
Pediatrix Medical Group, Inc. annual/quarterly ebitda history and growth rate from 2016 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Pediatrix Medical Group, Inc. ebitda for the quarter ending March 31, 2026 was 47.8 M, a 27.63% increase year-over-year.
- Pediatrix Medical Group, Inc. ebitda for the twelve months ending March 31, 2026 was 224.0 M, a 775.32% decrease year-over-year.
- Pediatrix Medical Group, Inc. annual ebitda for 2025 was 230.6 M, a 732.12% decrease from 2024.
- Pediatrix Medical Group, Inc. annual ebitda for 2024 was -36.5 M, a 183.89% decrease from 2023.
- Pediatrix Medical Group, Inc. annual ebitda for 2023 was 43.5 M, a 79.12% decrease from 2022.
- Pediatrix Medical Group, Inc. annual ebitda for 2022 was 208.3 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pediatrix Medical Group, Inc. EBITDA — FAQ
Pediatrix Medical Group, Inc. (MD) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MD's ebitda history?
The chart and table above show Pediatrix Medical Group, Inc.'s ebitda by year and by quarter, including the growth rate.